ABC | Volume 111, Nº6, Dezembro 2018

Minieditorial Grossman CM após revascularização percutânea em pacientes assintomáticos Arq Bras Cardiol. 2018; 111(6):794-795 1. HenzlovaMJ, Duvall WL, Einstein AJ, TravinMI, VerberneHJ. ASNC imaging guidelines for SPECT nuclear cardiology procedures: Stress, protocols, and tracers. J Nucl Cardiol. B2016;23(3):606-39. 2. Hendel RC, Berman DS, Di Carli MF, Heidenreich PA, Henkin PA, Pellikka PA, et al. ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM2009 appropriate use criteria for cardiac radionuclide imaging: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the American Society of Nuclear Cardiology, the AmericanCollege of Radiology, the AmericanHeart Association, the American Society of Echocardiography, the Society of Cardiovascular Computed Tomography, the Society for Cardiovascular Magnetic Resonance, and the Society of Nuclear Medicine. Circulation. 2009;119(22): e561-87. 3. Bourque JM, Beller GA. Stress myocardial perfusion imaging for assessing prognosis: an update. JACC Cardiovasc Imaging. 2011;4(12):1305-19. 4. HachamovitchR,HayesSW,FriedmanJD,Cohen I,BermanDS.Comparison oftheshort-termsurvivalbenefitassociatedwithrevascularizationcompared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation. 2003;107(23):2900-7. 5. Shaw LJ, Berman DS, Maron DJ, Mancini GB, Hayes SW, Hartigan PM, et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and AggressiveDrug Evaluation (COURAGE) trial nuclear substudy. Circulation. 2008;117(1):1283-91. 6. Wolk MJ, Bailey SR, Doherty JU, Douglas PS, Hendel RC, Kramer CM, et al. ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use for the detection and risk assessment of stable ischemic heart disease. J Am Coll Cardiol. 2014; 63(4):380-406. 7. de Andrade LF, Souza AC, Peclat T, BartholoC, Pavanelo T, Lima RSL. Ovalor prognósticoeousoclínicocintilografiadeperfusãomiocárdicaempacientes assintomáticos após intervenção coronariana percutânea. Arq Bras Cardiol. 2018; 111(6):784-793 8. Rajagopal V, Gurm HS, Brunken RC, Prothier EE, Bhatt DL, Lauer MS. Prediction of death or myocardial infarction by exercise single photon emission computed tomography perfusion scintigraphy in patients who have recent coronary artery stenting. AmHeart J. 2005;149(3):534-40. 9. Zellweger MJ, Fahrni G, Ritter M, Jeger RV, WildD, Buser PM, et al; BASKET Investigators. Prognostic value of “routine” cardiac stress imaging 5 years after percutaneous coronary intervention: the prospective long-term observational BASKET (Basel Stent Kosteneffektivitäts Trial) LATE IMAGING Study. JACC Cardiovasc Interv. 2014;7(6):615-21. 10. Maron DJ, Hochman JS, O’Brien SM et al. International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design. AmHeart J. 2018; 201:124-35. Referências Este é um artigo de acesso aberto distribuído sob os termos da licença de atribuição pelo Creative Commons 795